Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase II, Randomized, Double-blind, Placebo-controlled Study of a Controlled Release Minicapsule Formulation of Ciclosporin (CyCol™) in the Treatment of Mild to Moderate Ulcerative Colitis

NCT01033305 is registered in ClinicalTrials.gov with Sigmoid Pharma as lead sponsor.

NCT NCT01033305
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01033305 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase II, Randomized, Double-blind, Placebo-controlled Study of a Controlled Release Minicapsule Formulation of Ciclosporin (CyCol™) in the Treatment of Mild to Moderate Ulcerative Colitis
Lead sponsor
Sigmoid Pharma
Phase
Phase 2
Overall status
Completed
Start date
March 31, 2010
Completion date
September 30, 2011
Enrollment
118 (actual)
Sites
22

Conditions

As the registry lists them; a condition with its own page is linked.

mild to moderate ulcerative colitis